A 58-year-old man with newly diagnosed type 2 diabetes (HbA1c 8.2% despite lifestyle measures) has BMI 31 kg/m², eGFR 75 mL/min/1.73 m² and no established cardiovascular disease. According to Australian primary care guidance, what is the most appropriate initial pharmacological therapy?